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a b s t r a c t
Gram-negative bacterial outer membrane proteins play important roles in the interaction of
bacteria with their environment including nutrient acquisition, adhesion and invasion, and
antibiotic resistance. In this study we identified 47 proteins within the Sarkosyl-insoluble
fraction of Campylobacter jejuni 81-176, using LC–ESI-MS/MS. Comparative analysis of outer
membrane protein sequences was visualised to reveal protein distribution within a panel of
Campylobacter spp., identifying several C. jejuni-specific proteins. Smith–Waterman analyses
of C. jejuni homologues revealed high sequence conservation amongst a number of hypo-Proteomics
Outer membrane
Genomics
thetical proteins, sequence heterogeneity of other proteins and several proteins which are
absent in a proportion of strains.
© 2014 The Authors. Published by Elsevier B.V. on behalf of European Proteomics
Association (EuPA). This is an open access article under the CC BY license
stood. Gram-negative bacterial outermembrane (OM) proteins
represent a group of factors which play important roles in the1. Introduction
Campylobacter spp. are the commonest cause of food-borne
disease worldwide accounting for 2.4 million cases per year
in the US (www.cdc.gov/foodnet) with Campylobacter jejuni
and C. coli responsible for the majority of infections. In the
developing world these organisms are the leading cause of
gastrointestinal infection in children under 2 years of age
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[1]. Additionally, post-infection sequelae may arise including
Guillain–Barré syndrome (GBS) and other debilitating neuro-
logical disorders [2,3]. Despite a significant worldwide effort,
mechanisms of disease and immunity remain poorly under-ce Park, Bush Loan, Penicuik EH26 0PZ, UK. Tel.: +44 1314455111;
id.G.E.Smith@moredun.ac.uk (D.G.E. Smith).
enome Campus, Hinxton, Cambridge, United Kingdom.
nd Systems Biology, The King’s Buildings, The University of Edin-
interaction of bacteria with their environment. These include
porins and nutrient uptake systems, iron acquisition proteins,
European Proteomics Association (EuPA). This is an open access
y/3.0/).
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irulence factors, proteins involved in antibiotic resistance
nd other proteins required for survival within the hostile
n vivo environment.
To date, functional roles have been ascribed to only a dozen
r so C. jejuni OM proteins. A more comprehensive character-
sation of this important group of proteins, even in prototypic
trains, has yet to be reported. Several C. jejuni surface pro-
eins have been observed to play roles in adhesion. Three of
hese, CadF and FlpA, and PEB1 have been shown to play a role
n the colonisation of broiler chicks [4,5]. Additionally, JlpA,
apA and PorA appear to mediate binding to epithelial cells in
ulture [6–8]. Another important role is the transportation of
mall molecules across the bacterial cell membrane. C. jejuni
acks the phosphofructokinase protein and cannot there-
ore metabolise glucose although recently some strains were
hown to use fucose as a substrate for growth [9,10]. Instead,
he bacterium utilises amino acids as a source of carbon and
nergy; the surface proteins PEB1, andCjaA are components of
BC transporters with roles in aspartate/glutamate, and cys-
eine uptake respectively [11,12]. OM efflux systems are also
mportant: CmeC and CmeD are OM components of two func-
ionally characterised multi-drug efflux pumps, which have
oles in antimicrobial and bile resistance [13,14]. Omp50 and
orA have been characterised as porins and the former was
ecently shown to play a role in phosphotyrosine network reg-
lation [15–17]. Campylobacter spp. also possess a number of
ron acquisition systems, components of which reside in the
M including the Fe3+ enterobactin binding proteins CfrA and
frB [18–20] and theheme transporter ChuA, [21]. Flagella have
variety of proposed roles in C. jejuni virulence and protein
omponentswhich anchor flagella to themembrane (FlgH) are
ocated in the OM [22]. OM proteins may also elicit patholog-
cal host responses; the surface-exposed lipoprotein JlpA is
elieved to trigger signalling events, which lead to inflamma-
ion [23].
Interrogation of the C. jejuni genome has revealed that
number of protein complexes and chaperones, which are
ssential formembrane biogenesis inmanywell characterised
ram-negative bacteria, are either divergent or absent alto-
ether within C. jejuni genomes [24]. The -barrel assembly
achinery is known as the Bam complex [25]. The closest
omologue of the OM localised component, BamA (formerly
nown as YaeT), is divergent in C. jejuni and, to the best of
ur knowledge, homologues of BamBCDE, are not found at all
ithin Epsilonproteobacteria genomes. LolB of the Lol (lipopro-
ein localisation) complex, which is responsible for sorting
ipoproteins [26] is absent in Epsilonproteobacteria, although
omologues of other proteins within this complex are present
n C. jejuni genomes. C. jejuni also varies from the majority of
ther Gram-negative bacteria in that it lacks the O-antigen of
PS. Often referred to as LOS (lipooligosacharide), this is per-
aps a reflection of the divergence of the Lpt (LPS transport)
roteins which are required for insertion of LPS into the
uter membrane. This suggests that alternative mechanisms
f maintaining membrane integrity and biogenesis have yet to
e revealed within C. jejuni and related bacteria. Existing evi-
ence suggests that distinct mechanisms for OM biogenesis
xist outside theGammaproteobacteria group of bacteria [27,28].
he divergence in this cellular machinery for protein sorting
lso suggests that conventional in silico protein localisation( 2 0 1 4 ) 184–194 185
tools may not be reliable for this particular group of bacteria
and therefore localisation of these proteins by experimental
methods is particularly pertinent.
Approximately one third of C. jejuni predicted open reading
frames (ORFs) code for proteins of unknown function and it
is unlikely that the current list of characterised OM proteins
is complete. Therefore, a thorough analysis of expressed OM
proteins is essential for identifying factors important to and
possibly novel to C. jejuni pathogenesis. We performed pro-
teomic analysis of the OM of C. jejuni subsp. jejuni 81-176, a
widely employed strain which causes experimentally repro-
ducible clinical disease [29]. A variety of methods have been
used previously for membrane protein enrichment although
the fractions of extracted proteins vary in composition. The
most comprehensive proteome analysis of C. jejuni to date
focussed on the entiremembrane compartment, i.e.periplasm
and both inner and outer membranes [30]. Campylobacter OM
appears to be closely associated with the inner membrane
and as a result is more challenging to purify [31]. Recently,
Hobb et al. [32] reported that N-lauroylsarcosine (Sarkosyl)
treatment of C. jejuni cells was the most successful method
of isolating specifically OM proteins. Furthermore, Sarkosyl
enrichment is often used to predict localisation of Campylobac-
ter proteins [15,33,34].
The low solubility of OM proteins renders them incompati-
blewith themajority of proteomic techniqueshence gel-based
proteomics offers a convenient method for their analysis as
issues associated with hydrophobicity are circumvented by
ionic detergent (sodium dodecyl sulfate) solubilisation and
subsequent in-gel tryptic digestion [35,36]. In this study, a
rapid shotgun proteomics-based approach was used to cata-
logue the protein complement of the C. jejuniOM fraction. This
methodology, comprising SDS-PAGE, one-dimensional mono-
lithic column liquid chromatography, electrospray ionisation
(ESI) and fast MS/MS scanning, is colloquially termed “sawn-
off shotgun proteomic analysis” (SOSPA). This approach
enables the analysis of membrane-associated and other
hydrophobic proteinswhilst simultaneously combining rapid-
ity with breadth of coverage. Bioinformatic approaches
were deployed to survey the resulting SOSPA-generated
data to identify homologous proteins amongst bacterial,
Epsilonproteobacteria and, particularly, Campylobacter genomic
sequences.
2. Materials and methods
2.1. Bacterial strains, media and culture conditions
C. jejuni 81-176 (pVir+) is a well characterised strain, isolated
from contaminated milk [37]. Bacteria were grown at 37 ◦C in a
variable atmosphere incubator (Don Whitley Scientific, Ship-
ley, UK) in an atmosphere of 6% hydrogen, 5% carbon dioxide,
5% oxygen, and 84% nitrogen. Bacteria were cultured for 48h
onCampylobacter selective agar (Skirrow) plates (E&OLaborato-
ries, Bonnybridge, UK) then resuspended in 20ml high glucose
Dulbecco’s modified Eagle’s medium (cat. 11960, Invitrogen,
Paisley, UK), supplemented with 20mM l-glutamic acid and
0.00125% iron ascorbate (Sigma, Dorset, UK) [38] at anAbs600 of
mics186 e u pa open proteo
0.1. Cultures were incubated statically for 34h; the timepoint
was chosen to represent growth in late log phase.
2.2. OM protein enrichment
OM protein enrichment was carried out as described by Gau-
thier et al. [39]. Bacteria from broth cultures were pelleted
at 8000× g and resuspended in 500l of 50mM Tris–HCl
(pH 7), with 20% sucrose, 10M EDTA, 10g/ml lysozyme
and protease inhibitors (Complete Mini EDTA Free, Roche
Diagnostics Ltd, Burgess Hill, UK) for 10min at room temper-
ature. All subsequent steps were carried out on ice. Bacteria
were centrifuged at 8000× g for 10min and the supernatant
removed. The pellet was resuspended in 1ml Tris buffer
(10mM Tris–HCl, pH 7) with protease inhibitors and soni-
cated on ice (amplitude 5.0, 6×15 s). Unbroken bacteria were
removed by centrifugation at 16,000× g for 2min and the
supernatant was centrifuged for 1h at 50,000× g to pellet bac-
terialmembranes. Pelletedmembraneswerewashedwith Tris
buffer, resuspended in Tris–Sarkosyl buffer (Tris buffer con-
taining 0.5% (w/v) N-lauroylsarcosine), and centrifuged for 1h
at 50,000× g. TheOMpelletwaswashed inTris–Sarkosyl buffer
then resuspended in Tris–Sarkosyl buffer containing 0.1% SDS.
2.3. LC–ESI-MS/MS
Sarkosyl-insoluble proteins, prepared as described above,
were resolved on a 4–12% Bis–Tris NuPAGE SDS-PAGE gradient
gel (Invitrogen, Paisley, UK) in MES Buffer at 200V (constant
voltage) over 45min. Proteins were visualised using Colloidal
Coomassie Blue G250 (Sigma, Dorset, UK). Molecular size stan-
dards were included routinely on gels. LC–ESI-MS/MS was
carried out essentially as described by Batycka et al. [40]. For
each sample lane, a series of gel slices of equal size (2.5mm),
covering the entire lane, were excised from the SDS-PAGE
gel before performing standard in-gel de-staining, reduction,
alkylation and trypsinolysis procedures [41]. The samples
were transferred to HPLC sample vials and stored at +4 ◦C
until required for LC–ESI-MS/MSanalysis. Liquid chromatogra-
phy was performed using a Dionex Ultimate 3000 nano-HPLC
system (Thermo Fisher Scientific, Hemel Hempstead, UK)
comprising a WPS-3000 well-plate micro auto sampler, a FLM-
3000 flow manager and column compartment, a UVD-3000 UV
detector, an LPG-3600 dual-gradient micropump and an SRD-
3600 solvent rack controlled by Chromeleon chromatography
software (www.thermoscientific.com/dionex). A micro-pump
flow rate of 246l/min−1 was used in combination with a
cap-flow splitter cartridge, affording a 1/82 flow split and a
final flow rate of 3l/min−1 through a 5 cm×200m ID mono-
lithic reversed phase column (Thermo Fisher Scientific, Hemel
Hempstead, UK) maintained at 50 ◦C. Samples of 4l were
applied to the column by direct injection. Peptides were eluted
by the application of a 15min linear gradient from 8% to
45% solvent B (80% acetonitrile, 0.1% (v/v) formic acid) and
directed through a 3nl UV detector flow cell. LCwas interfaced
directly with a 3-D high capacity ion trap mass spectrometer
(EsquireHCTplusTM, BrukerDaltonics, Bremen,Germany) via a
low-volume (50l/min−1 maximum) stainless steel nebuliser
(Agilent Technologies, Wokingham, UK; cat. no. G1946-20260)
and ESI. Parameters for tandem MS analysis were set as4 ( 2 0 1 4 ) 184–194
previously described [40]. Technical controls included BSA
standard and a blank gel slice.
2.4. Database mining
Deconvoluted MS/MS data were searched against an
annotated cognate chromosomal and plasmid C. jejuni
81-176 protein database derived from genomic sequences
available at the National Centre for Biotechnology Informa-
tion (Genbank), http://www.ncbi.nlm.nih.gov (Table 1) and
the NCBInr C. jejuni sub-database, using MASCOT software
(Matrix Science, London, UK) [42]. Analysis was performed in
accordance with published guidelines [43]. To this end, fixed
and variable modifications selected were carbamidomethyl
(C) and oxidation (M) respectively and mass tolerance values
for MS and MS/MS were set at 1.5Da and 0.5Da respectively,
permitting one missed cleavage. Positive protein identifi-
cations were based on recognition of a minimum of two
peptides, each with an unbroken series of four or more “b”
or “y” ions [40]. Deconvoluted MS/MS data in .mgf (Mascot
Generic Format) were imported into ProteinScapeTM pro-
teomics data analysis software (Bruker Daltonics, Bremen,
Germany) which compiles data from all gel slices utilising
the MASCOT search algorithm (Matrix Science, London, UK).
The protein content of individual gel slices was established
using the “protein search” feature of ProteinScapeTM, whilst
separate compilations of the proteins contained in all 25 gel
slices of each of the three biological replicates were produced
using the “protein extractor” feature of the software. Data
was searched specifying Trypsin and Trypsin/P. Spectra used
for protein identifications were re-searched against the entire
NCBInr database to ensure accurate peptide assignments.
2.5. Amino acid sequence comparison tools
Protein sequences were compared by two methods. First,
an in-house Java application which takes a single reference
genome in protein multi-FastA and annotation information
in .ptt formats (http://www.ncbi.nlm.nih.gov/sites/genome),
plus several user-defined comparison genomes in protein
multi-FastA format. This tool uses BLASTP [44] to define puta-
tive orthologs between reference and comparison genomes
and displays a graphical alignment of these proteins show-
ing alignment score, metadata and an amino acid alignment.
The Campylobacter genomes examined are listed in Table 1.
NCBI genomedatasets comprised (i) Epsilonproteobacteria class,
excluding the Campylobacter genus, and (ii) all bacterial
genomes excluding the Epsilonproteobacteria class. Second,
Smith–Waterman global alignments [45] were carried out
between protein pairs. Smith–Waterman scores were nor-
malised using the score for identical sequences as reference
(100%) to take account of the disparity in protein length. Scores
were displayed as a heat map.
2.6. Bioinformatic toolsThe LipoP 1.0 Server (http://www.cbs.dtu.dk/services/LipoP/)
was used to predict N-terminal signal peptides in lipoproteins
[46]. The -barrel outer membrane protein predictor (BOMP)
server (http://services.cbu.uib.no/tools/bomp) and Phyre2
e u pa open proteomics 4 ( 2 0 1 4 ) 184–194 187
Table 1 – Genomes used in this study.
Bacteria Source Accession Ref. Genome status
Genbank RefSeq
Query sequences
C. jejuni subsp. jejuni 81-176 Contaminated milk CP000538 NC 008787 [37] Complete
NZ AASL00000000 [74] Draft
C. jejuni subsp. jejuni 81-176 pVir CP000550 NC 008770 Complete
C. jejuni subsp. jejuni 81-176 pTet CP000549 NC 008790 – Complete
Subject sequences
C. jejuni subsp. jejuni 1336 Water/wildlife isolate CM000854 NZ ADGL00000000 [75] Draft
C. jejuni subsp. jejuni 260.94 GBS strain from the Red Cross
Children’s Hospital in Cape Town,
South Africa
AANK01000000 NZ AANK00000000 – Draft
C. jejuni subsp. jejuni 327 Turkey skin surface ADHM00000000 – [76] Draft
C. jejuni subsp. jejuni 414 Bank vole ADGM00000000 NZ ADGM00000000 [75] Draft
C. jejuni subsp. jejuni 81116 Waterborne outbreak CP000814 NC 009839 [77,78] Complete
C. jejuni subsp. jejuni 84-25 Cerebrospinal fluid of a child with
meningitis can go systemic
AANT00000000 NZ AANT00000000 – Draft
C. jejuni subsp. jejuni CF93-6 MFS patient in Japan AANJ00000000 NZ AANJ00000000 Draft
C. jejuni subsp. jejuni CG8421 Bloody diarrhoea patient in
Thailand
ABGQ00000000 NZ ABGQ00000000 [79] Draft
C. jejuni subsp. jejuni CG8486 Inflammatory diarrhoea patient in
Thailand
AASY00000000 NZ AASY00000000 [80] Draft
C. jejuni subsp. jejuni DFVF1099 Isolated from chicken
slaughterhouse
ADHK00000000 – [81] Draft
C. jejuni subsp. jejuni HB93-13 Faeces of 8-year-old boy in China
with acute motor axonal
neuropathy form of GBS
AANQ00000000 NZ AANQ00000000 – Draft
C. jejuni subsp. jejuni IA3902 Sheep abortion CP001876 – [82] Complete
C. jejuni subsp. jejuni ICDCCJ07001 GBS patient CP002029 NC 014802 [83] Complete
C. jejuni subsp. jejuni M1 Diarrheic patient CP001900 – [84] Complete
C. jejuni subsp. jejuni NCTC11168 Diarrheic patient AL111168 NC 002163 [24] Complete
C. jejuni subsp. jejuni RM1221 Skin of a retail chicken CP000025 NC 003912 [85] Complete
C. jejuni subsp. jejuni S3 Chicken faeces CP001960 – [86] Complete
C. jejuni subsp. doylei 269.97 Blood of bacteremia Patient CP000768 NC 009707 – Complete
C. coli RM2228 Chicken carcass AAFL01000000 NZ AAFL00000000 [85] Draft
C. coli JV20 Multi-drug-resistant chicken
isolate
AEER01000000 NZ AEER00000000 [85] Draft
C. upsaliensis RM3195 GBS patient AAFJ01000000 NZ AAFJ00000000 [85] Draft
C. lari RM2100 Clinical isolate CP000932 NC 012039 [85] Complete
C. curvus 525.92 Gastrointestinal clinical isolate CP000767 NC 009715 – Complete
C. concisus 13826 Gastrointestinal clinical isolate CP000792 NC 009802 – Complete
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C. hominis ATCC BAA-381 Faeces of healthy human
Protein Homology/analogY Recognition Engine V 2.0) (http://
ww.sbg.bio.ic.ac.uk/phyre2/), were used to predict the pres-
nce of -barrels within protein sequences [47,48]. Functional
omains and motifs were identified in protein sequences
sing Interproscan server (www.ebi.ac.uk/interpro/) using all
vailable methods [49].
. Results and discussion
.1. LC–ESI-MS/MS identification of C. jejuni strain
1-176 Sarkosyl-insoluble proteins
trict confidence criteria were used when assigning peptide
nd protein identities [43]. To ensure reproducibility, only pro-
eins represented by two peptides in at least two of three
eplicates are presented here (Table 2). Sequence coverage
as determined using only top ranking peptides. Using the
rypsin/P setting of ProteinScapeTM, which allows detectionCP000487 NC 008599 – Complete
CP000776 NC 009714 [87] Complete
of peptides generated by occasional trypsin digestion between
lysine or arginine and proline [50], 8 additional peptides were
identified, including one which defined l-lactate permease.
All matches are found in Tables S1–S6 of the supplementary
data.
Applying those criteria, 47 proteins were identified
confidently within the Sarkosyl-insoluble material. These
comprised several previously characterised OM proteins
including the adhesins CadF and FlpA, theMapAantigen and a
number of proteins with known roles in small molecule trans-
port including the porins PorA and CJJ81176 1185 (Omp50),
ABC transporter components PEB1, CjaA and CjaC and the
multi drug efflux pump component CmeC. Two iron acquisi-
tion proteins ChuA and CfrB were also identified as well as the
membrane associated flagellar component, FlgL, the flagellar
hook protein (FlgE), hook-associated protein (FlgH) and both
flagellin proteins, FlaA and FlaB, which are enriched under the
same conditions as OM proteins [22].
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Table 2 – Proteins identified by LC–ESI-MS/MS analysis of C. jejuni 81-176 OM. Number of non-redundant peptides and
sequence coverage are given for each biological replicate.
Locus tag NCBI annotation Gene No. of peptides % Coverage Mr
1 2 3 1 2 3
CJJ81176 0019 Conserved hypothetical protein – 6 3 1 36.4 19.2 5.1 24.3
CJJ81176 0025 Flagellar hook protein FlgE flgE 35 35 32 65.9 65.4 58.6 89.4
CJJ81176 0056 l-Asparaginase ansA 9 9 8 41.4 31 36.5 36.9
CJJ81176 0067 Gamma-glutamyltransferase ggt 8 5 8 18.5 10.1 18.5 60.3
CJJ81176 0113 l-Lactate permease lctP 3 1 4 8.4 3.6 9.5 60.1
CJJ81176 0116 Cytolethal distending toxin, subunit A cdtA 3 – 3 12.3 12.3 29.9
CJJ81176 0124 Lipoprotein, putative – 4 3 7 12.8 8.2 20.5 51.3
CJJ81176 0125 Lipoprotein, putative – 3 3 4 28.7 27 38.5 14.1
CJJ81176 0126 Lipoprotein, putative – 10 10 10 53.1 53.1 53.1 22.4
CJJ81176 0127 Hypothetical protein – 8 15 15 29.7 52.1 49.7 49.3
CJJ81176 0148 Peptidoglycan-associated lipoprotein
Omp18
– 5 5 5 33.9 33.9 33.9 17.8
CJJ81176 0164 Outer membrane protein, OMP85
family
– 15 13 18 24.8 23.8 31.9 83.1
CJJ81176 0205 Superoxide dismutase, Fe sodB 3 1 4 14.1 7.7 21.8 24.8
CJJ81176 0356 Antioxidant, AhpC/Tsa family ahpC 4 2 1 29.8 17.7 11.6 21.9
CJJ81176 0388 RND efflux system, outer membrane
lipoprotein CmeC
cmeC 7 7 4 22.6 21.3 15 55.4
CJJ81176 0419 Lipoprotein, putative – 4 6 4 18.7 32.2 19.3 37.3
CJJ81176 0430 Lipoprotein, putative – 3 1 8 11.4 3.7 32.8 33.2
CJJ81176 0471 TonB-dependent receptor, putative,
degenerate
cfrB 5 10 10 10.1 21.4 21.3 79.2
CJJ81176 0499 Translation elongation factor Tu tuf 4 1 3 19.5 5 12.8 43.6
CJJ81176 0586 Conserved hypothetical protein – 5 7 7 20.1 30.7 30.4 35.0
CJJ81176 0641 Nonheme iron-containing ferritin ftn 9 8 8 62.3 58.7 58.7 19.5
CJJ81176 0710 Flagellar L-ring protein FlgH flgH 2 4 4 15.1 27.2 34.1 25.2
CJJ81176 0757 cjaC protein cjaC 8 7 10 47.4 36.3 45 27.8
CJJ81176 0800 Thiol peroxidase Tpx 3 4 5 24 34.9 46.3 18.4
CJJ81176 0894 Flagellin family protein flgL 5 7 7 10.7 14.8 14.1 81.9
CJJ81176 0928 Amino acid ABC transporter,
periplasmic amino acid-binding
protein PEB1
pebA 5 – 4 30.5 – 23.6 28.1
CJJ81176 0974 Conserved hypothetical protein – 6 6 6 53.5 54.2 43.1 16.2
CJJ81176 1001 CjaA protein cjaA 8 7 10 36.2 31.9 46.2 30.9
CJJ81176 1016 Conserved hypothetical protein – 2 4 2 13.2 23.7 13.2 20.5
CJJ81176 1045 Lipoprotein, putative – 5 7 6 52 41.5 55.6 18.5
CJJ81176 1048 Outer membrane lipoprotein MapA mapA 7 8 7 40.2 51.9 42.1 24.1
CJJ81176 1108a Lipoprotein, putative – 2 2 2 26.3 26.3 26.3 12.7
CJJ81176 1185 Conserved hypothetical protein 4 9 9 15.7 27.7 23.6 52.6
CJJ81176 1204 Methyl-accepting chemotaxis protein – 4 3 8 30.9 23 52.7 19.3
CJJ81176 1268a Organic solvent tolerance protein,
putative
– – 2 3 – 4.6 6.5 79.6
CJJ81176 1275 Major outer membrane protein porA 19 21 18 66.3 65.8 64.6 45.7
CJJ81176 1295 Fibronectin type III domain protein flpA 14 13 11 47.3 45.6 41.7 46.1
CJJ81176 1338 Flagellin flaB 26 25 24 65.8 64.4 58.7 59.7
CJJ81176 1339 Flagellin flaA 29 28 27 66.5 68.1 62.3 59.5
CJJ81176 1367 Serine protease, subtilase family – 3 1 5 5.5 1.2 5.8 116.2
CJJ81176 1374 Lipoprotein, VacJ family 2 1 2 9.5 4.7 9.5 26.4
CJJ81176 1471 Fibronectin-binding protein cadF 11 11 11 48 43.6 42.3 36.0
CJJ81176 1519 Bacterioferritin, putative – 5 4 4 47.7 35.6 38.3 17.2
CJJ81176 1601 TonB-dependent heme receptor chuA 7 8 16 13.7 15.8 33 80.0
CJJ81176 1690 Ribosomal protein S8 rpsH 3 – 4 35.9 – 42 14.7
CJJ81176 pVir0002 VirB9 – 1 2 3 3.7 7.6 11.2 40.8
CJJ81176 pVir0048 Conserved hypothetical protein –
a Sequences with re-assigned start codons were used.
Three lipoproteins, which are encoded by a locus of
three genes, were also identified (CJJ81176 0124, CJJ81176 0125
and CJJ81176 0126). Oakland et al. [51] recently charac-
terised homologues of these lipoproteins in strain NCTC11168
(Cj0089, Cj0090, and Cj0091). Few autotransporter proteins4 2 5 39.2 21.5 47.7 15.0
are annotated in C. jejuni yet they are common features
of Gram-negative bacterial outer membranes. In this study
we detected the expression of one putative autotransporter,
the serine protease CJJ81176 1367. Bioinformatic analysis
of this protein shows several features of autotransporters
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ncluding the -strand repeat (IPR013425) and -barrel domain
IPR005546).
The roles of Omp18 (CJJ81176 0148), Omp85 (CJJ81176 0164)
nd the putative organic solvent tolerance protein
CJJ81176 1268) have not been investigated in C. jejuni
lthough homologues of these proteins in other bacteria
re involved in maintenance of membrane integrity and
iogenesis. Omp18 is also known as peptidoglycan associated
rotein (Pal), which is a component of the well charac-
erised Tol-Pal envelope complex [52]. Within Campylobacter
enomes, Omp85 is the closest homologue of BamA, which
n other Gram-negative bacteria is the OM component of the
-barrel assembly complex [25]. The protein annotated as
putative organic solvent tolerance protein is the closest
ampylobacter homologue to E. coli LptD (LPS transport) [53].
isruption of a Helicobacter pylori homologue, OstA (29%
equence identity with CJJ81176 1268) resulted in an increase
n membrane permeability, susceptibility to hydrophobic and
-lactam antibiotics and sensitivity to organic solvents [54]
nd possibly performs a similar role in C. jejuni.
Eleven further gene translation products were also identi-
ed, including nine uncharacterised proteins of chromosomal
rigin and two plasmid encoded proteins – VirB9, and the
ypothetical protein CJJ81176 pVir0048.
Several proteins identified in this study are by consensus
onsidered to be cytoplasmic, although homologues of super-
xide dismutase (SOD), thiol peroxidase (Tpx), bacterioferritin
Dps), gamma-glutamyltransferase (GGT) and l-asparaginase
ave been localised to the OM in the closely related H. pylori
55–58]. Esposito et al. [59] speculated that the localisation of
OD in H. pylori may be due to an extended C-terminal tail, a
eature shared with Campylobacter SOD. Protein CJJ81176 1519
s annotated as a putative bacterioferritin although was char-
cterised by Ishikawa et al. [60] as a Dps (DNA protection
uring starvation) protein, a protein class which is widely dis-
ributed in bacterial species and are members of the ferritin
uperfamily. The protein with highest sequence similarity
o CJJ81176 1519 outside Campylobacter spp. is NapA of H.
ylori, a surface exposed adhesin [61]. GGT, a component of
he antioxidant glutathione pathway, is required for persis-
ent colonisation of the avian intestine by C. jejuni 81116 [62]
lthough GGT is not present in all C. jejuni isolates, including
trains NCTC11168 and RM1221. Elongation factor Tu (EF-Tu)
s central to protein synthesis in the cytoplasm although it
s now considered to play a variety of roles within the cell
nd has been localised to the OM of Gram-negative bacte-
ia, including Neisseria meningitidis [63] as well as the surface
f Mycoplasma pneumoniae and Lactobacillus johnsonii where it
s thought to contribute to host adhesion [64–66]. Thus, as
ncreasingly shown for other bacteria, C. jejuni may express
on-classically associated OM “moonlighting” proteins on its
urface with potential roles in infection.
.2. Suggested re-annotation of C. jejuni strain
1-176 open reading frameshe annotation of CJJ81176 1108 as a putative lipoprotein and
resence of -barrel domain of CJJ81176 1268 suggest OM
ssociation of both proteins although their annotated amino
cid sequences lack signal peptides. Closer examination of the( 2 0 1 4 ) 184–194 189
genome sequences upstream from the annotated sequences
within the 81-176 genome (NC 008787) for CJJ81176 1108 and
CJJ81176 1268 revealed alternative translational start sites for
these sequences, resulting in an additional N-terminal 56
and 7 amino acids respectively. These alternative N-terminal
sequences contain intact lipoprotein signal peptides and are
annotated as translational start sites for orthologues in other
C. jejuni subsp. jejuni genomes in NCBI databases. Further-
more MS data searched against the revised sequence for
CJJ81176 1108 identified a peptide indicating expression of
this region of the protein. This evidence suggests that the
translational start codons for accession entries gi|121612654
and gi|121504146 are currently mis-annotated; the suggested
revised N-terminal sequences are shown Figure S1 of the sup-
plementary data.
3.3. Distribution of proteins across Campylobacter
species
We used in-house software to examine conservation and
sequence similarity of a selected panel of characterised and
uncharacterised OM proteins within Campylobacter genomes.
A graphical representation of sequence similarity is provided,
simultaneously facilitating the identification of conserved
determinants that may be important in Campylobacter fit-
ness and pathogenicity, heterogenous coding sequences, and
highlights the presence of potential species/strain-specific
markers. Fig. 1 shows comparisons for selected OM proteins
against Campylobacter species and strains and selected NCBI
datasets. This analysis demonstrates that the majority of OM
proteins are conserved amongst C. jejuni subsp. jejuni strains,
with the exception of the serine protease CJJ81176 1367 and
hypothetical proteinCJJ81176 0019 (discussed inmoredetail in
the next section). The results also indicate that there is little
sequence similarity between C. jejuni OM proteins and pro-
teins within Campylobacter spp. other than C. coli. The majority
of OM proteins shared high sequence similarity with proteins
present within both strains of C. coli although the lipoprotein
CJJ81176 0125, CJJ81176 1185 (Omp50), the hypothetical pro-
tein CJJ81176 0127 and the serine protease CJJ81176 1367 are
absent. Several OM proteins of strain 81-176 were revealed to
have high sequence similarity (up to 91%) with C. upsaliensis
and/or C. lari proteins, althoughmanyOMproteinswere diver-
gent or absent. Only a few protein sequences are conserved in
Campylobacter spp. curvus, concisus, fetus and hominis and the
remaining proteins are either divergent or absent completely.
Results of BLASTP searches of selected NCBI databases reveals
presence of conserved proteins within Epsilonproteobacteria
class (excluding the Campylobacter genus), as well as more
widely amongst bacteria.
3.4. Analysis of sequence variability of OM proteins
within C. jejuni isolates
Given the reported genetic variation within Campylobacter
strains and species [24], conservation and sequence similarity
of OM proteins in C. jejuni genomes were further investigated.
The Smith–Waterman algorithm was used to generate align-
ments, instead of the time-optimised BLAST algorithm, and
normalised scores were displayed as a heat map to allow
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Fig. 1 – Comparison of C. jejuni 81-176 OM protein amino acid sequences identified by LC–ESI-MS/MS with amino acid
sequences derived from 27 selected Campylobacter genomes and specified NCBI genomic datasets, using the BLASTP
algorithm. Reciprocal best hits are identified and represented graphically with the strength of homology shown as shaded
rectangles. Colour coding of C. jejuni 81-176 query sequences corresponds to Cluster of Orthologous Groups (COGs),
NCBallocated by National Center for Biotechnology Information (
greater discrimination (Fig. 2). Amino acid sequences for CadF,
CJJ81176 1268, Omp18/Pal, CJJ81176 0126, and the uncharac-
terised proteins CJJ81176 0430, CJJ81176 0974, CJJ81176 1016,
CJJ81176 1108, and CJJ81176 0419 are all highly conserved
across C. jejuni subsp. jejuni isolates, which suggests that these
are essential membrane proteins. Omp85, PEB1, and FlpA
were also found to be conserved, although some sequence
variations exist, all of which are predicted to be a result of
assignment of alternative start codons. Alternatively assigned
start codons are shown in Table S7 of the supplementary data.
Several proteins showed divergence across strains
with respect to sequence heterogeneity as well as pres-
ence/absence. PorA, ChuA, and CJJ81176 1185 (Omp50)
homologues exist in all C. jejuni subsp. jejuni strains but the
Smith–Waterman scores indicate divergence in sequence;
closer inspection of sequence alignments shows all three
proteins contain regions of variability. This is of particular
interest for Omp50, which was recently shown to coordinate
capsule formation via a tyrosine phosphorylation cascade [17].
Whether this sequence variability influences protein function
warrants further study. The variability of PorA is well docu-
mented and has been exploited in the development molecularI) which indicates predicted function.
epidemiology typing methods [67–70]. The serine protease
autotransporter CJJ81176 1367 is absent in strains M1, 81116,
and 327. Additionally, a divergent sequence is present within
strains ICDCCJ07001 and 260.94, although this sequence
shares stronger sequence similarity with CJJ81176 1376, an
additional sequence within the C. jejuni 81-176 genome.
CJJ81176 0019 is divergent in strains NCTC11168, DFVF1099,
CF93-6 and 84-25 and strains ICDCCJ07001 and 260.94 contain
truncated sequences (see below). The sequence is also absent
from the genome of strain HB93-13 although the region is
towards a contig boundary, hence truncation may be due to
incomplete sequence information.
Amino acid sequences of CmeC, CjaC, CjaA, MapA, the
lipoproteins CJJ81176 0124, CJJ81176 0125 and CJJ81176 1045
and theuncharacterisedproteinsCJJ81176 0019, CJJ81176 0127
and CJJ81176 0586, are conserved in the majority of C. jejuni
subsp. jejuni strains although in some strains either trunca-
tions or extended sequences are present due to frameshifts
or substitutions which result in stop codons. A summary of
truncations is given in Table S8 of the supplementary data
and indels are indicated. Such frameshifts may be of biolog-
ical importance as a truncated version of the protein may
e u pa open proteomics 4 ( 2 0 1 4 ) 184–194 191
Fig. 2 – Smith–Waterman analysis of sequence similarity. Image represents scores for Smith–Waterman global alignments,
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ihich were carried out between protein pairs. Scores take a
heat map (black=100% and white=0% identity). Regions o
esult in altered virulence, metabolic capability or survivabil-
ty. Some truncations are of considerable size, and in some
ases the resulting protein sequences are annotated as pseu-
ogenes althoughannotation of someORFs in different strains
s inconsistent. Some proteins are found to be truncated in
any strains; truncations of CjaC are foundwithin five strains,
ll of which appear to be due to frameshifts. Diversity within
jaC has been reported previously [71]. Many truncationswere
bserved to occur as a result of insertions/deletions within
omopolymeric tracts. Notably, the tracts are A or T rather
han G or C which is more commonly documented in Campy-
obacter spp. Although it is tempting to speculate that these A
r T homopolymeric tracts may allow a rapidly adaptive and
eversible alteration in OM protein composition and a poten-
ial survival/adaptation strategy, it is more likely that many of
hese indels are a result of the high error rate in high through-
ut sequencing of homopolymeric regions.
Ironavailability is a critical requirement for bacteria, result-
ng in diverse uptake mechanisms. Several iron acquisition
ystems have been identified in C. jejuni, many with OM com-
onents. Variation in distribution of these systems is well
ocumented and is discussed in a review by Miller et al. [18].
equence analysis of the ferric enterobactin receptor CfrB also
eveals a degree of variation within coding sequences for this
rotein. An intact coding sequence for CfrB is present within
trains ICDCCJ07001, 260.94, HB93-13, 81116, M1, and 327.
rameshifts resulting in truncated proteins in strains 84-25,
FVF1099 and CF93-6 were also observed. Manual inspec-
ion revealed that within NCBI protein sequence databases for
trains NCTC11168, RM1221, S3, IA3902, CG8421 and CG8486,
he protein with closest sequence similarity to CfrB is the
ron binding protein CfrA, which is not found within thent of the disparities in protein lengths and are displayed as
omplete sequence and protein truncations are indicated.
strain 81-176 genome. Despite the absence of annotated pro-
tein sequences within the databases held at NCBI for several
strains, homologous nucleotide sequences similar to cfrB are
present in all genomes, although several sequences contain
indels which results in their exclusion from annotated protein
sequence databases. A summary of frameshifts and resulting
outcomes is shown in Table S9 of the supplementary data. Sig-
nificantly, all genomeswith truncatedCfrBproteins contain an
intact coding sequence for CfrA and conversely, genomes with
highly similar CfrB sequences lack CfrA indicating a greater
conservation in strains without the alternative CfrA system.
Divergence in environmental isolates and C. jejuni subsp.
doylei 269.97 is also apparent. Strain 414 and, to a lesser extent,
strain 1336 showdivergence in several proteinswhich are con-
served in other C. jejuni subsp. jejuni strains. Fig. 2 shows that
several proteins conservedwithinC. jejuni subsp. jejuni isolates
are absent from C. jejuni subsp. doylei. C. jejuni subsp. doylei is
associated with both gastritis and enteritis and more com-
monly bacteraemia, particularly in paediatric patients, and
has been frequently isolated from blood cultures [72].
4. Concluding remarks
In 2008, Cordwell et al. carried out a comprehensive investiga-
tion of the membrane compartment of C. jejuni although this
analysis was not restricted to the OM as it included the inner
membrane and periplasmic space [30]. Membrane-associated
proteins are typically hydrophobic, thus in order to investi-
gate the proteome of the OM compartment of C. jejuni 81-176,
we enriched Sarkosyl-insoluble bacterial proteins and applied
a gel-based proteomics approach. Characterisation of the OM
mics
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compartment is paramount to understanding pathogenicity,
and it is also important to establish the distribution of these
factors within strains. Equally, proteins conserved within
disease-causing species which are absent in non-pathogenic
species suggest a potential requisite for pathogenicity.We also
investigated conservation of a panel of OM proteins within
selected genomic datasets. Whilst it is apparent that individ-
ual isolates may contain a diversity of proteins within the
OM, it is also clear that a number of proteins are conserved; a
largeproportionof these remain functionally uncharacterised,
however.
The similarities between C. jejuni and H. pylori OM
emphasise a requirement for further characterisation of
Epsilonproteobacteria OM, for which common biological pro-
cesses are already known to differ from those of the
well-studied Enterobacteriaceae [73]. Since protein content
varies both quantitatively and qualitatively in response to
environmental cues, future efforts will examine homogeneity
and heterogeneity of protein expression within and between
strains under different culture conditions and phases of
growth, in response to specific stimuli and upon interaction
with hosts. The results presented here reinforce the notion
that C. jejuni should be considered as heterogeneous bacte-
ria with potential for considerable variability at the genotypic,
phenotypic and ultimately pathogenic levels.
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